June Trades

The DOW was up in early June, but came back down to end the month about the same as where it started. Negative news about the virus weighed down on the markets. I sold my 50 shares of Abbvie (ABBV) when it got to $98.47 for a $1,243.58 gain. I then bought 100 shares of Gilead Sciences (GILD) at an average price of $75.78 per share. And, I bought 150 shares of Fidelity National Financial (FNF) at $32.75 per share. My thinking on FNF is that, with low interest rates, people that have money will be buying real estate. Plus, they currently have a 4.38% dividend. I also added another 50 shares of Pfizer (PFE). In my closed end fund portfolio I added to ETY and PFN. In my IRA account I added shares of Fidelity MSCI Real Estate Index ETF (FREL). This real estate ETF has mainly cell tower companies and pays a 4% dividend. This is my attempt to make up for the lack of money market dividends. As it sits today, my cash flow from non-IRA investments is $526 per month. My mortgage will be dropping to $381 per month in September and my credit card bill is usually around $395 per month. So, I’m still about $250 away from covering my share of expenses with investment income each month. I have to show $3000 in gains from stock trades to cover the rest. As of July 4th, I have $2,124 in gains. So, let’s hope they release a vaccine soon, and the market continues to recover.